• 9 Oct 2025

Claire Sintrat

Claire is a Managing Director at Keensight Capital.

She brings more than 15 years of investment and M&A experience, with a special focus on Healthcare.
Claire was previously Head of M&A at Keensight Performance where she was responsible for the M&A activity across the portfolio.

Prior to joining Keensight, Claire was a Director in the Healthcare Investment Banking team at Jefferies in London. She executed numerous cross-border M&A, equity and debt transactions across a range of healthcare sectors.

Claire also spent part of her career in investment banking at Nomura and HSBC in London, and in Transaction Services at Deloitte.

Claire has a British-French dual nationality. She is a Chartered Accountant and holds a double Bachelor’s degree in European Management, from Lancaster University (UK) and NEOMA Business School (France).

Resources & Insights

  • 9 Mar 2026
  • Rob Crook
High Throughput Experimentation: Fully Integrated or Modular System?
  • Chemical Development
  • High Throughput Experimentation
  • Process R&D
  • Thought Leaders
  • 5 Feb 2026
2nd Advances in Translational Drug Development 2026
  • Events
  • 4 Feb 2026
  • Loïc Roux
Make as Insight, Not Execution – Why “Make” Is the Most Misunderstood Step in DMTA
  • Design-Make-Test
  • DMTA
  • Thought Leaders
  • 22 Jan 2026
  • Loïc Roux
Designing Therapeutic Oligonucleotides – A Practical Framework from Biology to Sequence Selection
  • Design-Make-Test
  • DMTA
  • Oligonucleotides
  • Thought Leaders